Fibroblasts and myofibroblasts in the tumor microenvironment are important players in tumor growth and metastasis because of their unique ability to coordinate events which increase cell proliferation and invasion especially in breast cancer. It has been experimentally shown that fibroblasts play an important role in promoting tumor growth. Our study illustrates a model in which tumor cells are able to communicate with these fibroblasts/myofibroblasts through proteinases for active invasion toward stroma near breast ducts.
Introduction
It is well established that tumor microenvironment affects tumor growth and metastasis [43] . Understanding the relationship between tumor and its microenvironment may lead to important new therapeutic approaches in controlling the growth and metastasis of cancer. Indeed, instead of targeting the tumor cells, one may target stromal elements in order to manipulate the host-tumor interaction in a way that it will confine the tumor [6, 31] . Thus, for instance, modulating cell adhesion or blocking Matrix Metalloproteinase (MMP) may be novel ways of confining cancer.
The tumor microenvironment includes various cell types such as epithelial cells, fibroblasts, myofibroblasts, endothelial cells and inflammatory cells. These cells communicate with one another and influence each other's behavior by means of the cytokines and growth factors they secrete. Fibroblasts are of particular interest because both in vitro and in vivo studies have shown that they contribute to the formation and growth of tumors [17] . A recent study of a chemotherapeutic drug for breast cancer, for instance, has found that a strong stroma reaction characterized by an increased number of fibroblasts surrounding the tumor is likely to have a bad response to this drug [12] . Myofibroblasts, described as activated fibroblasts with smooth muscle differentiation, are abundant in the stroma of malignant breast tissue, but rarely seen in normal breast tissue [44] . Active pro- [13, 21] .
liferation of myofibroblasts and, in turn, increased collagen deposition near tumor regions are characteristics of many solid tumors [48] . Whereas in situ carcinoma myofibroblasts predominantly reside in the immediate periphery of the developing carcinoma, after the transition to invasive breast cancer myofibroblasts migrate to the invading front [48, 15] . These differences in both the abundance and location of myofibroblasts most likely stem from signals sent by epithelial cells in which oncogenic changes have occurred.
Initial expression of proteases in human breast cancer may be associated with the transition from Ductal Carcinoma in Situ (DCIS) to invasive ductal carcinoma. Expression studies of MMP in human DCIS material have shown that several classes of MMPs are expressed in periductal fibroblasts and myofibroblasts, indicating an intense stromal involvement during early invasion [2] . As reported in [14] , disruption of the extracellular matrix (ECM) and cellular microenvironment caused by overexpression of MMPs-3,-7 or -14 in the mammary gland is sufficient to initiate mammary epithelial hyperplasia. See Figure 1 .
In order to understand the interaction between tumor cells and fibroblasts/myofibroblasts at early stages of cancer, Kim et al. [22] considered an in vitro situation where transformed epithelial cells (TECs) and fibroblasts are placed in a transwell, separated by a semipermeable membrane (see also [16] ). The results from experiments showed good agreement with the numerical results from the PDE model, and hence confirmed the model's ability to predict the behavior of tumor cells in response to signals from the stromal cells (fibroblasts). Other experiments were conducted with ECM-plated membrane to mimic a basement membrane. See [52, 21] for a review. These experiments measure the chemotactic force by which various molecules from one chamber attract tumor cells from another chamber. These experiments also quantify the influence of different compositions of the ECM layer on the invasion. Kim and Friedman also extended the previous model and monitored the entire invasion process in silico, in a setup which mimics experiments in a Boyden Invasion Assay, where a porous membrane coated by ECM is placed between two chambers [21, 22] . In their PDE model, both tumor cells and fibroblasts are allowed to migrate to other chambers. The model was used to explore several hypotheses on how to slow tumor growth and invasion.
In this paper we have developed a mathematical model of the early stage of cancer development when tumor epithelial cells in DCIS enter the vicinity of the basal membrane and may invade the stroma. The mathematical model is a mixture of mechanical equations and reaction-diffusion equations. The former describes the movement of the cells and the basal membrane in a viscous fluid and is solved by the immersed boundary (IB) method [38, 53, 29, 28] . The latter describes the concentrations of ECM and proteinases, and is solved by the alternating direction implicit (ADI) method together with the nonlinear system solver nksol. A new aspect of this paper is that we keep track of positions of tumor cells and stromal cells, and model breaches in the breast duct wall. Therefore, the mathematical model in this paper may provide a general framework that can be applicable in both industrial and theoretical settings, and it may also help researchers generate several hypotheses on how to block tumor invasion.
Mathematical model
In this section we first formulate equations of motion that describe how invasive TECs generate active forces and determine the direction of migration, and summarize an algorithm of the numerical method.
Mechanics
In the model we consider tumor epithelial cells enclosed by the basal membrane. Both the basal membrane and the tumor cells can be represented by elastic closed loops immersed in a viscous fluid. Here the elastic membrane is tethered in stroma, see Figure  2 . The IB method is used to simulate the interaction between the fluid and the structure (the tumor cells and the basal membrane). The fluid is governed by the incompressible Navier-Stokes equations. Let X(s, t) = X c (s, t) X B (s, t) be the configura-
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Epithelial cells Fibroblasts Myofibroblasts Figure 2 : Illustration of our mechanics model. tion of the structure at any time t, where s is a moving curvilinear coordinate. Here, X c represents the cells which are surrounded by the basal membrane X B . The coupled system of equations of motion is as follows:
Fluid Eqs. (2.1) and (2.2) are the Navier-Stokes equations of a viscous incompressible fluid. u(x, t) is the fluid velocity, p(x, t) is the fluid pressure, and f (x, t) is the applied fluid force density defined on the fixed Cartesian coordinates x = (x 1 , x 2 ). The constant parameters ρ and µ in the fluid equations are the fluid density and the fluid viscosity, respectively.
Eq. (2.3) is the immersed boundary equation. F (s, t) is the force density which acts on the fluid by the immersed boundary. There are four contributions to the force density function F : the elastic force density F c e from the cell boundary, the active force density F c a of cells for migration, the elastic force density F B e from the membrane, and the tethered force density F B t of the membrane. These force densities are given by
In Eqs. (2.6)-(2.7), E c and E B are the elastic energy functionals with respect to the configurations X c and X B , respectively. In Eq. (2.8), Z B is the reference configuration of the membrane and c s is the stiffness constant. In Eq. (2.9), c a is the force constant, k P is an invasiveness parameter, n is the order in a Hill type function, and d is the unit vector in the moving direction, which depends on locations and concentrations of molecules in microenvironment. During invasion, the basal membrane is degraded by MMPs and this degraded portion will not generate the force as a result. We assume that there is a threshold of the basal body degradation to generate force and this threshold depends on the level of MMPs at the site.
Lastly, Eqs. (2.4)-(2.5) are the interaction equations that connect the fluid equations and the immersed boundary equation by the two-dimensional Dirac delta function δ. Eq. (2.4) describes the relationship between the two corresponding force densities f (x, t)dx and F (s, t)ds. Eq. (2.5) is the no-slip condition, which means the structure moves at the local fluid velocity.
Let Ω = [0, 1] × [0, 1] be the computational domain of the model in a two-dimensional space. To solve the above equations on Ω numerically, we discretized the equations in space and time using a finite difference scheme. In particular, we used FFTs (Fast Fourier Transform) to solve the discretized Navier-Stokes equations where the fluid domain is periodic. For a detailed description of the numerical scheme, the reader is referred to [37, 29] .
Reaction-diffusion
The governing equations for concentrations of ECM (M ), tumor cell associated proteinase (P ), and fibroblast-secreted proteinase (G) [21] are as follows:
where x n i , x f i are the sites of TECs and fibroblasts/myofibroblasts, respectively. V 0 and V * are the cell volume and reference ECM volume, respectively, and other parameters are positive constants. We prescribe Neumann boundary conditions:
where ν is the outward normal. We finally prescribe initial conditions:
Equations (2.10)-(2.15) were solved on the same computational domain Ω using an ADI scheme [47] and a nonlinear solver nksol [5, 11] for algebraic systems. We solved these equations on a uniform grid with mesh width h=0.01 and used adaptive time stepping which adjusts the size of time step according to error and stability conditions. Since the center of motile tumor cells and source sites of migratory fibroblasts/myofibroblasts are not necessarily on the regular grid, these concentration values (M, P, G) at the sites in the production/degradation terms were interpolated to grid points [24] .
An algorithm
We take the following algorithm for computation: step 0. Initialization. step 0.1 Set a regular, uniform grid for Ω and initialize concentrations of ECM (M ), tumorassociated proteinase (P ), and fibroblastsecreted proteinase (G) at each lattice point.
step 0.2 Set the locations of the basal membrane and fibroblasts outside the duct and tumor cells inside the duct.
Step 1. Locate all cells and basal membrane nodes that are within a given distance from cell i. Use the level of fibroblast-secreted proteinase in order to determine invasive cells and target the basal membrane to be degraded. Step 2. Determine the moving direction of a cell when its invasion is activated. The migration direction is perpendicular to the tangent vector at the front node of invasive cells, i.e., cells cross the basal membrane by degradation.
Step 3. Deformation and translation of cells.
Step 3.1 Find all the forces that act on the cell from each of the neighbor cells found in Step 1. Active forces are generated by invasive cells that has been activated by fibroblast-secreted proteinase at the site.
Step 3.2 Determine whether proteinase levels reach the threshold value to degrade the basal membrane. When this happens, the degradation of the basal membrane occurs. This is done by removal of tethered forces from the basal membrane.
Step 4. Calculate the force density acting on the fluid by Eq. (2.3) and smear it out into the fluid grid by Eq. (2.4).
Step 5. Update the fluid velocity and fluid pressure using Eqs. (2.1)-(2.2).
Step 6. Move the structure at the new local fluid velocity using (2.5).
Step 7. Solve the reaction-diffusion equations (2.10)-(2.15) on a regular grid, using the ADI method, lagging the consumption term.
Step 8. Go to Step 1.
All parameter values used in this work are shown in Table 1 Figure 3 shows the typical time evolution of cell migration and a profile of the fibroblast-secreted proteinase at an early time when it initiates the basal membrane degradation and tumor cell invasion into the stroma. Figure 4 shows the time evolution of concentrations of ECM (M ) and the tumor-associated proteinase (P ) at the corresponding times, as shown in Figure 3 . For illustration purposes, the domain of Figure 4(a-h) Note that the center of the breast duct was located at the center of the computational domain Ω. As invading tumor cells migrate to the left, ECM is degraded by tumor-associated proteinase and continue to remodel the structure through reconstruction. This track of ECM and tumor-associated proteinase is associated with sites of migrating tumor cells. Fibroblastsecreted proteinase diffuses to the region near the duct, which initiates the degradation of the basal membrane by TECs inside the duct. Once this gate is open, TECs actively migrate into stroma. As TECs are activated to migrate into stroma, ECM is degraded by proteolytic activity via localized tumor-associated proteinase. A frontier cell, the first to escape, leads the way to further stromal regions by allowing space for cells inside a breast duct. Note that the deformation of the invasive cells occurs when they escape from the duct. This elongation of cells is experimentally observed when invasive cells are passing through the mechanically challenging structure, the basal membrane in the breast duct. Figure 5 shows the effect of rate (a 5 ) of fibroblastsecreted proteinase production on invasiveness of tumor cells near a breast duct. Different dimensionless values of a 5 were used; a 5 =20.0, 23.0, 24.0, 54.0, 94.0. As a 5 decreases, the initiation of basal membrane degradation slows down. Consequently, without whole or partial blocking of fibroblast-secreted proteinase, more cells enter into the stroma for further interaction with other cells such as immune cells and endothelial cells in a microenvironment leading to serious metastasis. Once tumor cells are out of the duct, it is much harder to control tumor growth due to their ability to obtain more genetic mutations through interaction with elements in the microenvironment and to modify the microenvironment [30, 7] . Due to the well-known role of MMPs, blocking the MMP pathway of tumor cells has been a common strategy by developing inhibitors of MMPs such as tissue inhibitor of metalloproteinases (TIMP), but has had little success. Instead of targeting the proteolytic activity of tumor cells within the duct, one can take a combined strategy of blocking both fibroblast-secreted proteinase and tumor-associated proteinase. Our results indicate that the early prevention of initiation of basal membrane degradation would be a much more effective way to block further tumor invasion into stroma. Figure 6 illustrates the role of cell motility (fibroblasts) in the initiation of TEC invasion into the stroma. When these fibroblasts/myofibroblasts are not allowed to migrate toward the duct (m = 0), blocking the production of fibroblast-secreted proteinase (G) is effective, i.e., TEC does not initiate degradation of the basal membrane for the whole simulation time. However, when these fibroblasts/myofibroblasts are allowed to migrate toward the duct with a motility m = 0.5 or m = 1, the proteinase source from fibroblasts/myofibroblasts moves toward the duct to promote the initiation of basal membrane degradation by TECs within the duct. This result indicates that blocking of this proteinase is not enough to prevent the initiation of cancer invasion into the stromal region. A therapeutic drug that blocks both the fibroblast-secreted proteinase and fibroblast motility would be more effective at inhibiting the initiation of proteolytic activity of TECs within the duct.
Results
4 Discussion and future work This paper concerns the relationship between cancer and its microenvironment at the early stage of cancer development. More specifically, it considers invasive cancer. Understanding the relationship between a tumor and its microenvironment may lead to important new therapeutic approaches in controlling the growth and metastasis of cancer. Instead of targeting the tumor cells, one may target stromal cells in order to manipulate the host-tumor interaction in a way that prevents the tumor invasion. The changed (remodelled) microenvironment creates the elevated interstitial fluid pressure (IFP) creating chemoresistance. To improve the outcome of cancer therapy, researchers have developed several drugs targeting tumor associated fibroblasts (TAFs) or tumor associated macrophages (TAMs) [6] . The drugs targeting TAF include agents for Platelet-derived growth factor receptor (PDGFR) (Imatinib [39] , SU11248 [32] , BAY43-9006 [51] , CDP860 [18] ) and fibroblast activation protein (Sibrotuzumab [25] , DNA vaccine, PT-100 [1] ). The goal of developing these drugs is to "normalize" IFP [6] . We note that FAP can function as a serine protease that cleaves ECM components such as gelatin and collagen, contributing to ECM remodeling [20] .
Our numerical results indicate that the tumor invasion is reduced by introducing an inhibitor that blocks secretion of proteinase by fibroblasts/myofibroblasts. This means that we could target the FAP by developing more effective drugs using proven anti-FAP compounds such as Sibrotuzumab [25] and PT-100 [1] . However, our results also indicate that the fibroblasts may overcome the decrease in interaction with tumors due to the diffusion limit by active migration toward the duct in order to better promote tumor-stroma interaction. Therefore, one may need to inhibit the pathways of proteinase and motility-related proteins such as integrin, which is consistent with the current view of the importance of integrin as a therapeutic target in breast cancer metastasis [6] . Our simulation results show the non-uniform deformation of cells when they invade the stroma. This deformation of tumor cells is a typical but important process for migration through the basal membrane. It is not well understood how the basal membrane degradation and tumor invasion are coordinated, especially in the midst of chemical signals between stroma and tumor cells. Therefore, our model provides a general framework for understanding mechanical aspects of cell migration through the basal membrane as well as the role of various proteinases from both fibroblasts and tumor cells. The articles by Paszek et al. [34, 35] provide a review of the mechanical aspects of stroma-tumor interactions near a breast duct. In spite of tremendous efforts for anti-cancer drug development, the outcome is still poor and the microenvironment is blamed for this chemoresistance. Overall, our new model can be used to test the hypotheses on developing more effective chemo-agents systematically, connecting this academic theoretical framework to pharmaceutical industry.
The results of the present work can serve as a starting point for more comprehensive modeling and experimentation. The future model may include the following: (a) Important molecules within the signalling pathways of the important communicators, epidermal growth factor (EGF) and Transforming growth factor (TGF-β); for example, anti-proliferation SMAD [26, 27, 8] and cytokines. (b) Other important molecules in proteolytic activity such as plasminogen, Urokinase-type plasminogen activator (uPA) and TIMP [3] .
(c) Mechanical feedback from the stroma near the breast duct known to be associated with tumor growth in situ as well as in modulation of progression/invasion in breast cancer [34, 35] . (d) Recruitment of inflammatory cells and angiogenesis which follows the lead of invasive TECs into the stroma, and contributes to an environment of metastatic potential [13] . Taking such factors into consideration will require multi-scale modeling that involves inter-and intracellular communication as well as cell population dynamics; some multiscale (hybrid) models have been developed in other contexts of tumor growth [24, 46] .
While it is a good approximation of averaged cells, a partial differential equations model [21] is not capable of tracking the location and behavior of individual cells. To our knowledge, the IB method has not been applied to active cell migration in the context of breast cancer, although it has been used for cell proliferation [40] . While lattice-free, cell-based models for active cell migration [9] and passive tumor growth [21] have been suggested, the morphology of invasive cells has not been explored. Our model provides a novel approach to investigate the mechanical aspects of cell migration with better descriptions of cell structure. The current model also provides a framework for a multiscale model where intercellular processes (signal transduction pathways) can be taken into consideration. But any model that includes the intercellular processes will involve invasion at an early stage of cancer progression. In this sense the present paper is a first step toward more comprehensive models of invasion and metastasis.
